Biochemical aspects of the pathogenesis of the thalassemia syndromes.
D000743:Anemia, Hemolytic / Q000235:genetics / Q000473:pathology; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism; D001854:Bone Marrow Cells; D002287:Carcinoma, Krebs 2 / Q000378:metabolism; D002474:Cell-Free System; D004247:DNA / Q000096:biosynthesis; D004905:Erythrocyte Aging; D004912:Erythrocytes / Q000166:cytology; D004920:Erythropoiesis; D005914:Globins / Q000096:biosynthesis; D006454:Hemoglobins / Q000096:biosynthesis; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D066298:In Vitro Techniques; D002479:Inclusion Bodies; D010452:Peptide Biosynthesis; D011132:Polyribosomes / Q000378:metabolism; D011487:Protein Conformation; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D012156:Reticulocytes / Q000378:metabolism; D013789:Thalassemia / Q000097:blood* / Q000235:genetics
D006454:Hemoglobins; D012333:RNA, Messenger; D005914:Globins; D004247:DNA